Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: A Bayesian analysis

• Main Authors: Ngo-Giang-Huong N., Jourdain G., Amzal B., Sang-a-gad P., Lertkoonalak R., Eiamsirikit N., Tansuphasawasdikul S., Buranawanitchakorn Y., Yutthakasemsunt N., Mekviwattanawong S., McIntosh K., Lallemant M.
• Format: Article
• Language: English
• Published: 2014
• Online Access: http://www.scopus.com/inward/record.url?eid=2-s2.0-81755171915&partnerID=40&md5=570728c5b9e4fe4eaf033839728c53bc; http://cmuir.cmu.ac.th/handle/6653943832/871

Background: WHO recommends starting therapy with a non-nucleoside reverse transcriptase inhibitor (NNRTI) and two nucleoside reverse transcriptase inhibitors (NRTIs), i.e. nevirapine or efavirenz, with lamivudine or emtricitabine, plus zidovudine or tenofovir. Few studies have compared resistance pa...